cp wire

CP Wire Articles

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

Vedanta Biosciences announced on 11/6/18 preclinical data for VE800, the Company’s orally-administered, live biotherapeutic product candidate in immuno-oncology. The study showed that VE800... read more

Wed, 11/7/18 - 11:15 pm
Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology


Synlogic, Inc. (Nasdaq: SYBX) announced on 11/6/18 the presentation of preclinical data from its first immuno-oncology (IO) program at the 33rd Annual Meeting & Pre-Conference Programs of... read more

Wed, 11/7/18 - 11:05 pm
SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study

SkinBioTherapeutics plc (AIM: SBTX) announced on 11/7/18 positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential.

As... read more

Wed, 11/7/18 - 10:53 pm
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development

With a growing body of science linking gut microbiota to inflammatory bowel disease (IBD), a need exists in clinical settings to understand changes in the gut microbial community as they relate to... read more

Wed, 11/7/18 - 01:02 pm
FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation
  • The FDA also previously granted orphan drug designation for cannabidiol in the treatment of autoimmune hepatitis
  • Revive is developing cannabinoid pharmaceuticals to treat rare... read more
Wed, 11/7/18 - 09:23 am

Pages